Literature DB >> 6585546

Pharmacokinetic analysis of concentration-time data obtained following administration of drugs that are recycled in the bile.

W A Colburn.   

Abstract

A pharmacokinetic model for calculating the pharmacokinetic parameters for a compound that is recycled in the bile is presented and tested using theoretical as well as experimental data. The results indicate that this method is stable and only slightly susceptible to sampling and recycling times. It is apparent from the present study that pharmacokinetic terms that have been used in classical situations are not directly applicable to drugs that enter the enterohepatic circulation. Effective half-life and effective clearance are used to describe the intrinsic ability of the eliminating organs to remove drug from the blood, whereas net half-life and net clearance are used to describe the irreversible elimination of the drug from the body.

Mesh:

Substances:

Year:  1984        PMID: 6585546     DOI: 10.1002/jps.2600730308

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  10 in total

1.  General treatment of the enterohepatic recirculation of drugs and its influence on the area under the plasma level curves, bioavailability, and clearance.

Authors:  J E Peris-Ribera; F Torres-Molina; M C Garcia-Carbonell; J C Aristorena; L Granero
Journal:  Pharm Res       Date:  1992-10       Impact factor: 4.200

2.  Mean residence time for drugs subject to enterohepatic cycling.

Authors:  T A Shepard; G F Lockwood; L J Aarons; I D Abrahams
Journal:  J Pharmacokinet Biopharm       Date:  1989-06

3.  Effect modelling for drugs undergoing enterohepatic circulation.

Authors:  P Höglund; M Ohlin
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1993 Oct-Dec       Impact factor: 2.441

4.  Estimation of area under the curve for drugs subject to enterohepatic cycling.

Authors:  T A Shepard; R H Reuning; L J Aarons
Journal:  J Pharmacokinet Biopharm       Date:  1985-12

5.  Factors affecting the kinetics of two benzothiazine non-steroidal anti-inflammatory medicines, piroxicam and isoxicam.

Authors:  I R Edwards; D G Ferry; A J Campbell
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

6.  Physiologic and metabolic influences on enterohepatic recirculation: simulations based upon the disposition of valproic acid in the rat.

Authors:  G M Pollack; K L Brouwer
Journal:  J Pharmacokinet Biopharm       Date:  1991-04

7.  Analysis of enterohepatic circulation of cefixime in rat by fast inverse Laplace transform (FILT).

Authors:  K Yamaoka; M Kanba; Y Toyoda; Y Yano; T Nakagawa
Journal:  J Pharmacokinet Biopharm       Date:  1990-12

8.  The disposition and elimination of stereoisomeric pairs of thioridazine 5-sulfoxide in the rat.

Authors:  P W Hale; S Melethil; A Poklis
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1985 Oct-Dec       Impact factor: 2.441

9.  Preclinical pharmacology of the antitumor agent O-6-methylguanine in CDF1 mice.

Authors:  V I Avramis; K K Chan; M M Solorzano; Z L Chen
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

10.  The operational multiple dosing half-life: a key to defining drug accumulation in patients and to designing extended release dosage forms.

Authors:  Selma Sahin; Leslie Z Benet
Journal:  Pharm Res       Date:  2008-11-18       Impact factor: 4.200

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.